Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study. [Clin Rheumatol. 2015]
Iannone, F., Gremese, E., Ferraccioli, G., Lapadula, G., Comment on “Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study”, <<CLINICAL RHEUMATOLOGY>>, 2016; 35 (3): 839-840. [doi:10.1007/s10067-015-2997-8] [http://hdl.handle.net/10807/94108]
Autori: | |
Titolo: | Comment on “Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study” |
Digital Object Identifier (DOI): | http://dx.doi.org/10.1007/s10067-015-2997-8 |
URL: | link.springer.de/link/service/journals/10067/index.htm |
Data di pubblicazione: | 2016 |
Abstract: | Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study. [Clin Rheumatol. 2015] |
Lingua: | Inglese |
Rivista: | |
Citazione: | Iannone, F., Gremese, E., Ferraccioli, G., Lapadula, G., Comment on “Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study”, <<CLINICAL RHEUMATOLOGY>>, 2016; 35 (3): 839-840. [doi:10.1007/s10067-015-2997-8] [http://hdl.handle.net/10807/94108] |
Appare nelle tipologie: | Articolo in rivista, Nota a sentenza |
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.